Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:awardReceived |
gptkb:Breakthrough_Prize_in_Life_Sciences
gptkb:Gairdner_International_Award |
| gptkbp:employer |
gptkb:Ionis_Pharmaceuticals
|
| gptkbp:fieldOfWork |
molecular biology
neuroscience |
| https://www.w3.org/2000/01/rdf-schema#label |
C. Frank Bennett
|
| gptkbp:knownFor |
antisense oligonucleotide therapeutics
Spinraza (nusinersen) |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
gptkb:pharmacy
|
| gptkbp:position |
Chief Scientific Officer
|
| gptkbp:bfsParent |
gptkb:Life_Sciences_Breakthrough_Prize_2019
|
| gptkbp:bfsLayer |
7
|